Article Information
History
- December 8, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Alican Özkan1,
- Gwenn Merry1,
- David B. Chou1,2,
- Ryan R. Posey1,
- Anna Stejskalova1,
- Karina Calderon1,
- Megan Sperry1,
- Viktor Horvath1,10,
- Lorenzo E. Ferri3,4,
- Emanuela Carlotti5,
- Stuart A. C. McDonald5,
- Douglas J. Winton6,
- Rocco Riccardi7,
- Lilianna Bordeianou7,
- Sean Hall1,11,
- Girija Goyal1 and
- Donald E. Ingber1,8,9,*
- 1Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA
- 2Department of Pathology, Massachusetts General Hospital, Boston, MA
- 3Thoracic and Upper GI Cancer Research Laboratories, Research Institute of McGill University Health Centre, Montreal, QC, Canada
- 4Department of Experimental Surgery and Department of Surgery, McGill University, Montreal, QC, Canada
- 5Clonal Dynamics in Epithelia Laboratory, Queen Mary University of London, London, United Kingdom
- 6Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, United Kingdom
- 7Department of Surgery, Massachusetts General Hospital, Boston, MA
- 8Vascular Biology Program and Department of Surgery, Boston Children’s Hospital and Harvard Medical School, Boston, MA
- 9Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, MA
- 10Current address: Entact Bio, Watertown, MA
- 11Current address: Iovance Therapeutics, Tampa, FL
- ↵*Address correspondence to: Donald E. Ingber, MD,PhD 201 Brookline Ave., Suite 401, Boston MA, 02215, USA em: don.ingber{at}wyss.harvard.edu
Posted December 08, 2024.
